Kamada (KMDA) Other Operating Expenses (2013 - 2025)
Kamada (KMDA) posted quarterly Other Operating Expenses of -$8000.0 for Q1 2025, down 700.0% on a QoQ basis from -$1000.0 in Q3 2020.
Kamada (KMDA) Other Operating Expenses (2013 - 2025) Analysis & Trends
Kamada (KMDA) has reported Other Operating Expenses for 8 consecutive years, with -$8000.0 the latest figure, recorded in Q1 2025.
- Quarterly Other Operating Expenses changed N/A year-over-year to -$8000.0 in Q1 2025, while the trailing twelve-month figure through Dec 2025 was -$8000.0 (changed N/A YoY) and the FY2025 annual result came in at -$8000.0, changed N/A from the prior year.
- Other Operating Expenses retreated to -$8000.0 in Q1 2025 per KMDA's latest filing, from -$1000.0 in the prior quarter.
- Over the last five years, Other Operating Expenses for KMDA reached as high as -$8000.0 in Q1 2025 and fell as low as -$8000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -8,000.00 |
| Sep 30, 2020 | -1,000.00 |
| Jun 30, 2018 | 4,000.00 |
| Sep 30, 2017 | -49,000.00 |
| Jun 30, 2017 | -45,000.00 |
| Mar 31, 2017 | 18,000.00 |
| Sep 30, 2016 | -32,000.00 |
| Jun 30, 2016 | 46,000.00 |
| Sep 30, 2015 | 111,000.00 |
| Jun 30, 2015 | -79,000.00 |
| Sep 30, 2014 | 69,000.00 |
| Jun 30, 2014 | 120,000.00 |
| Sep 30, 2013 | 64,000.00 |